Project Grant K23NS146693
- Federal Project Grant Award Summary New York Medical College received a $396,804 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective August 1, 2025 through July 31, 2026. The award supports the development and characterization of an animal model of Lennox-Gastaut Syndrome (LGS), a severe developmental epileptic encephalopathy affecting...
- Federal Grant Award Summary New York University received a $527,037 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective June 12, 2025, through May 31, 2030. The award funds research investigating neural representation of perceptual decisions, confidence, and actions in human basal ganglia and thalamus. The project leverages recordings...
- Federal Grant Award Summary New York University School of Medicine received a $254,250 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective September 25, 2025, with an anticipated completion date of August 31, 2027. The award supports the development of genetic approaches to study the organization and function of neocortical layer 1 (L1),...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $414,305 to the University of Wisconsin-Madison under its Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) effective August 1, 2025, with a completion date of July 31, 2027. This project grant funds fundamental neuroscience research aimed at identifying molecular mechanisms underlying epileptogenesis—the progressive development of spontaneous...
- Federal Grant Award Summary New York University School of Medicine received a $381,375 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372) on August 4, 2025. The award period extends through July 31, 2027. The project focuses on developing genetic strategies to study a novel disinhibitory system in the neocortex, specifically...
- Federal Project Grant Award Summary Albany Medical College received a $376,355 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective May 15, 2025, with a completion date of April 30, 2030. The project, titled "Microglial IGF1 in Epileptogenesis," funds fundamental neuroscience research investigating the role of insulin-like...
- Summary of Federal Project Grant Award The National Institute of Neurological Disorders and Stroke (NINDS) awarded New York Institute of Technology $459,000 under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The award, effective July 12, 2025, through June 30, 2028, funds a three-year research project investigating the anatomy and physiology of molecular layer heterotopia (MLH), a neuronal migration defect characterized by misplaced...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $238,356 to The Regents of the University of California, San Francisco under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) on August 15, 2025. This Project Grant supports a five-year research initiative (through July 31, 2030) investigating the amygdala-nucleus reticularis thalami (NRT) neural pathway and its influence on brain circuit...
- Federal Grant Award Summary New York University School of Medicine received a $164,516 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective May 1, 2025 through April 30, 2027. The award supports investigator-initiated research examining the relationship between cortical planning activity and disordered spoken interaction, with...
- Federal Grant Award Summary Boston University received a $657,958 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective June 1, 2025 through May 31, 2030. The research project focuses on elucidating the cellular and network mechanisms underlying spike ripples—a critical interictal biomarker for seizure risk in epilepsy—and examining how...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded New York University School of Medicine a Project Grant totaling $247,994 under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective March 1, 2026, with a completion date of April 30, 2031. Under this award, Dr. Andrew Michalak, Assistant Professor of Neurology at NYU Grossman School of Medicine, will conduct research to advance the understanding and treatment of drug-resistant epilepsy through investigation of ictal onset patterns (IOPs) and their utility in guiding responsive neurostimulation (RNS) implant placement and predicting patient outcomes. The research project delivers three primary scientific products: (1) identification of interictal neural mechanisms that generate IOPs using hybrid micro- and macroelectrode multiscale recordings; (2) quantification of the predictive value of IOPs for seizure reduction following RNS implantation; and (3) development and validation of machine learning neural networks to rapidly classify full ictal period patterns, replacing subjective and time-consuming manual classification methods. This work leverages NYU's high volume of surgical epilepsy cases and existing retrospective datasets, with mentorship from leading experts in multiscale electrophysiology, signal processing, and machine learning to bridge fundamental epilepsy mechanisms with therapeutic optimization for patients with drug-resistant seizures.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $248.0k | 2/20/26 |